The Pharmagellan Guide to Analyzing Biotech Clinical Trials
Product ID: 401812143
Buy anything from 5,000+ international stores. One checkout price. No surprise fees. Join 2M+ shoppers on Desertcart.
Desertcart purchases this item on your behalf and handles shipping, customs, and support to Spain.
The Pharmagellan Guide to Analyzing Biotech Clinical Trials : David, Frank S.: desertcart.co.uk: Books Review: best general book about clinical trials for strategists (regulatory, clinical, finance, etc) - It is very useful in due dilligence or any other multi-functional appraisal project of clinical trials, but is also a fantastic and up to date book for both advanced beginners and experts looking for a reference or good reading/recall of all main aspects of clinical trials. The author states that he has reviewed hundreds of books and articles about trials but hasn't found one as integrated like this one. I agree. I have also read hundreds of such books/articles on trials and they are usually either too operational (how to file an IND, Clinical trial application, monitor a clinical site, etc) or too narrow for one function/expert in one area (e.g. statistical analysis or any particular therapeutic area details). This book is unique in that indeed is a great resource for all therapeutic areas and functions. It provides an integrated perspective useful for strategists of new clinical trials programs of all functions from regulatory to commercial, from clinical to finance. Every major issue that can come up in a multi functional analysis of a trial is stated and explained. For example even the practice of endpoint switching at the last minute by biotech start ups or others eager to demonstrate results when they only have one shot (only funds for one clinical trial) at goal is covered with recent and relevant examples. Great job. Thank you so much to the author Frank David for a resource full of great and recent examples, extensive reference list of many aspects of clinical trials and how to handle them. Importantly, although is general for every particular issue the author is well-read in all aspects of clinical trials and refers you to more detailed texts about each topic that you may need to explore further in the particular clinical trial you are organizing or analyzing. Review: Honestly, it’s a great book. If you’re in biotech and you need a simplified overview of the intricacies of drug clinical trials and how they’re presented this is for you. It’s pretty unique in explaining statistical formulas and derivations of trial reporting as well as presenting the complexities of the the whole process. Waited a while to buy, but I’m glad I did. Worth the money if you read it cover to cover.
| Best Sellers Rank | 464,213 in Books ( See Top 100 in Books ) 163 in Bioengineering 352 in Medical Research & Equipment 3,862 in General Medical Issues Guides |
| Customer reviews | 4.2 4.2 out of 5 stars (38) |
| Dimensions | 15.24 x 1.85 x 22.86 cm |
| ISBN-10 | 0998407526 |
| ISBN-13 | 978-0998407524 |
| Item weight | 1.05 kg |
| Language | English |
| Print length | 292 pages |
| Publication date | 21 Jan. 2022 |
| Publisher | Pharmagellan |
P**O
best general book about clinical trials for strategists (regulatory, clinical, finance, etc)
It is very useful in due dilligence or any other multi-functional appraisal project of clinical trials, but is also a fantastic and up to date book for both advanced beginners and experts looking for a reference or good reading/recall of all main aspects of clinical trials. The author states that he has reviewed hundreds of books and articles about trials but hasn't found one as integrated like this one. I agree. I have also read hundreds of such books/articles on trials and they are usually either too operational (how to file an IND, Clinical trial application, monitor a clinical site, etc) or too narrow for one function/expert in one area (e.g. statistical analysis or any particular therapeutic area details). This book is unique in that indeed is a great resource for all therapeutic areas and functions. It provides an integrated perspective useful for strategists of new clinical trials programs of all functions from regulatory to commercial, from clinical to finance. Every major issue that can come up in a multi functional analysis of a trial is stated and explained. For example even the practice of endpoint switching at the last minute by biotech start ups or others eager to demonstrate results when they only have one shot (only funds for one clinical trial) at goal is covered with recent and relevant examples. Great job. Thank you so much to the author Frank David for a resource full of great and recent examples, extensive reference list of many aspects of clinical trials and how to handle them. Importantly, although is general for every particular issue the author is well-read in all aspects of clinical trials and refers you to more detailed texts about each topic that you may need to explore further in the particular clinical trial you are organizing or analyzing.
G**Y
Honestly, it’s a great book. If you’re in biotech and you need a simplified overview of the intricacies of drug clinical trials and how they’re presented this is for you. It’s pretty unique in explaining statistical formulas and derivations of trial reporting as well as presenting the complexities of the the whole process. Waited a while to buy, but I’m glad I did. Worth the money if you read it cover to cover.
R**A
Book ID thorough comprehensive clearly written and easy to follow. Highly recommend it.
F**E
Couldnt find new ideas or insights.
C**N
The book has many pages missing at the very beginning. This is an overseas purchase so it's quite inconvenient to return.
Trustpilot
3 weeks ago
2 weeks ago